Literature DB >> 27593800

Minimally Invasive Approach in Bilateral Chronic Subdural Hematomas: Surgical Selection and Outcome in 74 Cases.

Xu Min1, Yu Bo, Wang Cunzu, Zhu Xun, Lu Xiaofeng, Chen Pin, Zhang Hengzhu.   

Abstract

AIM: To investigate the effect of minimally invasive approaches on the outcome of bilateral chronic subdural hematoma.
MATERIAL AND METHODS: A retrospective analysis was performed in 74 hospitalized bilateral chronic subdural hematoma patients from January 2010 to January 2013 in Northern Jiangsu People's Hospital. Patients' gender, age, hematoma location, history of trauma, surgical approaches, the operation time, hospitalized time and follow-up three months after discharge were recorded. Prognostic indicators including symptom relief and post-hospital neuro-imaging findings were extracted. Statistical methods were conducted to evaluate surgical efficacy.
RESULTS: Both twist drill and burr-hole surgeries had a satisfying symptomatic relief (84.93%). Twist drill needs less operation time (p < 0.001) and less hospitalized time (p=0.001). Maximal width of hematoma in computed tomography (CT) findings was significantly different between twist drill group and burr-hole group (p=0.026). Maximal width in CT findings was significantly associated with follow-up outcomes (p=0.021).
CONCLUSION: Twist drill is a safe and effective minimally invasive surgery, especially for elderly patients with bilateral chronic subdural hematoma and a reasonable surgical operation seems to have more significant impact upon the surgical outcome.

Entities:  

Mesh:

Year:  2017        PMID: 27593800     DOI: 10.5137/1019-5149.JTN.16108-15.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  1 in total

1.  Minimally Invasive Surgery in Chronic Subdural Hematoma: Prognosis and Recurrence Factors of 516 Cases in a Single Center.

Authors:  Min Xu; Weiguo Tan; Wenhua Wang; Dongdong Wang; Wei Zeng; Cunzu Wang
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.